Authors


Vijayshree Yadav, MD, MCR, FANA, FAAN

Latest:

Investigating the Impact of a Low-Fat Diet on Quality of Life and Symptom Management in MS: Vijayshree Yadav, MD, MCR, FANA, FAAN

The professor of neurology at Oregon Health & Science University talked about a study on a modified low-fat diet intervention and its effects on fatigue in patients with multiple sclerosis over a 16-week period at CMSC 2023. [WATCH TIME: 8 minutes]


Anne W. Alexandrov PhD, RN, CCRN, ANVP-BC, NVRN-BC, FAAN

Latest:

Head-of-Bed Positioning Impact on Patients' Recovery Following Thrombectomy: Anne W. Alexandrov PhD, RN, CCRN, ANVP-BC, NVRN-BC, FAAN

The professor of nursing and neurology at the University of Tennessee Health Science Center talked about findings from a study investigating head-of-bed position in patients undergoing thrombectomy which was presented at ISC 2024. [WATCH TIME: 6 minutes]


Richard Bogan, MD, FCCP, FAASM

Latest:

Final Advice for Clinicians Treating Narcolepsy

Drs Thorpy, Dogan, Doghramji, and Kushida share clinical pearls for primary care providers who are taking care of patients with narcolepsy.


Mazen Elkurd, DO

Latest:

Seeking Clarity in Patient Stratification of Parkinson Disease: Mazen Elkurd, DO

The director of the Movement Disorders Center at Baylor University Medical Center in Dallas, a part of Baylor Scott & White Health, talked about the dilemma of stratifying patients with Parkinson disease based on various criteria and emphasized the need for a consensus on classification. [WATCH TIME: 3 minutes]


Forum Kamdar, MD, PhD, FACC, FHFSA

Latest:

NeurologyLive® Clinician of the Month Spotlight: Forum Kamdar, MD, PhD, FACC, FHFSA

As part of our monthly clinician spotlight, NeurologyLive® highlighted neuromuscular-associated cardiomyopathy expert Forum Kamdar, MD, PhD, FACC, FHFSA, an advanced heart failure physician-scientist at the University of Minnesota.


Hong Sun, MD, PhD

Latest:

The Potential of Nipocalimab as a Treatment for Autoantibody Mediated Diseases: Hong Sun, MD, PhD

The senior director and global compound development team leader at Janssen discussed research on nipocalimab, an investigational agent for patients with myasthenia gravis that's shown promising data to this point. [WATCH TIME: 2 minutes]


Arjun Masurkar, MD, PhD

Latest:

Understanding the Connection Between Alzheimer Disease Plasma Biomarkers and Gait Dysfunction: Arjun Masurkar, MD, PhD; Waijha Ahmed, MD

A group of clinician researchers at NYU Langone provided insight on a study presented at AAIC 2024 looking at the correlations between quantitative gait measures and Alzheimer disease biomarkers. [WATCH TIME: 4 minutes]



Dalia Rotstein, MD, MPH

Latest:

Beginning and Transitioning DMT in MS: Dalia Rotstein, MD, MPH

The assistant professor of medicine at University of Toronto, and neurologist at St. Michael's Hospital spoke about the process of changing or beginning treatment with a variety of disease-modifying therapies in multiple sclerosis. [WATCH TIME: 4 minutes]


Ada Metaxas, BS-C

Latest:

Applying the Innovation Biodesign Framework to Promote Equity and Green Activity in Dementia Care

Lassell et al present a use case demonstrating the process of moving an unmet need to the “solution space” of the Innovation Biodesign Framework for addressing a healthcare challenge in a specific at-risk population: Alzheimer disease and AD-related dementias.


Shae Datta, MD

Latest:

Raising Awareness for the Lasting Effects of Traumatic Brain Injury: Shae Datta, MD

The neurologist and migraine expert at NYU Langone Health provided perspective on TBI Awareness Month and the importance of accurate detection and swift care for trauamatic brain injury. [WATCH TIME: 4 minutes]


Ruth Benca, MD, PhD

Latest:

Assessing the Correlations With Sleep Issues and Risk of Dementia: Ruth Benca, MD, PhD

The professor and chair of Psychiatry & Human Behavior at Wake Forest School of Medicine provided insight on the signs and risks associated with sleep disorders and Alzheimer disease. [WATCH TIME: 3 minutes]


Susan Matulevicius, MD, MSCS

Latest:

AUPN Leadership Minute Episode 19: Happy Faculty-Happy Life: Improving Faculty Satisfaction

Episode 19 of the AUPN Leadership Minute features Mud M Alvi, MD, of West Virginia University; and Susan Matulevicius, MD, MSCS, of UT Southwestern Medical Center. [WATCH TIME: 4 minutes]


Stewart Factor, DO

Latest:

The Therapeutic Pipeline for Parkinson Disease: Stewart Factor, DO

The director of the Parkinson’s Disease and Movement Disorder Program at Emory University School of Medicine shared his perspective on the research and development of Parkinson therapies.


Bruce Hughes, MD

Latest:

Therapy Adjustments for Optimal, Early Intervention to Prevent Neurodegeneration in MS

The multiple sclerosis (MS) experts advise health care providers on how to impact the early onset of disease progression and prevent neurodegeneration in patients with MS.


Michael Woodward, MD, FRACP

Latest:

Refining Alzheimer Treatment Through Biomarker-Based Patient Selection: Michael Woodward, MD, FRACP; Anthony Caggiano, MD, PhD

The head of dementia research at Austin Health and the chief medical officer at Cognition Therapeutics talked about recently presented phase 2 findings on CT1812, an investigational medicine for patients with mild to moderate Alzheimer disease, at CTAD 2024. [WATCH TIME: 5 minutes]


Nicola De Stefano, MD, PhD

Latest:

Understanding the Clinical Advantages of Cladribine and its Impacts on Oligoclonal Bands: Nicola De Stefano, MD, PhD

The professor of neurology in the department of medicine, surgery, and neuroscience at the University of Siena, gave perspective on an analysis of the MAGNIFY-MS study, in which treatment with cladribine demonstrated impacts on CNS-related pathology in MS. [WATCH TIME: 4 minutes]


Nicholas Varvel

Latest:

Broad Anti-inflammatory Approaches Feasible for Epilepsy: Nicholas Varvel, PhD

The assistant professor in the department of pharmacology and chemical biology at Emory University School of Medicine spoke about immune cells in epilepsy based on his special lecture at the 2022 AES Annual Meeting. [WATCH TIME: 4 minutes]


Colin Josephson, MD, MSc, FRCPC

Latest:

Clinician and Patient Collaboration Advances Research and Epilepsy Care: Colin Josephson, MD, MSc, FRCPC

The associate professor of neurology at the University of Calgary spoke about advancing epilepsy care through patient-oriented research at the 2022 AES Annual Meeting. [WATCH TIME: 6 minutes]


Rebecca Whitney

Latest:

The Label of ‘Caregiver’

Rebecca Whitney, associate director of Programs and Community Support at SRNA and mother of child with a rare neuroimmune disorder, provided thoughts on the importance of caregivers and the role they play in everyday life.


Mill Etienne, MD

Latest:

AUPN Leadership Minute Episode 25: Patching the Holes in the Pipeline: Strategies to Enhance Diversity, Equity and Inclusion in Neurology

Episode 25 of the AUPN Leadership Minute features Tracey A. Milligan, MD, of New York Medical College; and Mill Etienne, MD, of New York Medical College. [WATCH TIME: 8 minutes]


Courtney Young, PhD

Latest:

Revolutionizing Treatment For Duchenne Muscular Dystrophy with Gene Editing: Courtney Young, PhD

The co-founder and chief executive officer of MyoGene Bio talked about the advantages of gene editing over traditional gene therapy as a long term treatment for neuromuscular diseases at MDA’s 2023 conference. [WATCH TIME: 3 minutes]


Melanie Quintana, PhD

Latest:

The Implementation of Platform Trials for ALS Research: Melanie Quintana, PhD

The senior statistical scientist and director of consulting at Berry Consultants talked about innovative clinical trial design in ALS research at the 2023 MDA conference. [WATCH TIME: 5 minutes]


Aparna V.R. Polavarapu, MD

Latest:

Aparna V.R. Polavarapu, MD: Early Treatment for Infantile Spasms

The pediatric neurologist at Montefiore Health System explains the importance of treating infantile spasms as early as possible and how it may impact outcomes.


Stuart J. Connolly, MD, FRCPC

Latest:

Key Takeaways From ANNEXA-I Study

Dr Connolly highlights the cautious patient selection and the significance of reducing hematoma expansion for improved outcomes in cases of intracerebral hemorrhage (ICH) associated with the use of a reversal agent for factor Xa inhibitors.


Rachel Alvarez

Latest:

Mission Behind Cure CMD’s Research Roundtable, Efforts Around CMDs: Rachel Alvarez

The executive director of Cure CMD discussed efforts being done to bring the stakeholder community together and improve the care for patients with congenital muscular dystrophies. [WATCH TIME: 4 minutes]


Patricia Melville, RN, MSN, NP-C, MSCN

Latest:

Concluding Thoughts on Biosimilars in Multiple Sclerosis

Amy Perrin Ross, APN, Patricia Melville, NP-C, Aliza Ben-Zacharia, PhD, DNP, ANP-BC, and John Kramer, PA-C share their advice for facilitating uptake of biosimilars in clinical practices.


Steven Arnold, MD

Latest:

Steven Arnold, MD: Assessing AMX0035 Efficacy in Alzheimer Disease

The managing director of the Interdisciplinary Brain Center at Massachusetts General Hospital discussed the process of determining the best situations for use of AMX0035.


Andy Berkowski, MD, PhD

Latest:

Exploring Gaps in RLS Treatment Through New 2024 Guidelines: Andy Berkowski, MD, PhD

The vice chair of the American Academy of Sleep Medicine’s Clinical Practice Guidelines Task Force commented on some of the unanswered questions following the recently published guidelines for restless legs syndrome. [WATCH TIME: 3 minutes]


Sameea Husain-Wilson, DO

Latest:

Role of Alpha-Synuclein in Accurate and Early Diagnosis of Parkinson Disease: Sameea Husain-Wilson, DO

The neurologist and director of movement disorder neurology at the Marcus Neuroscience Institute discussed how the Syn-One test utilizes alpha-synuclein and what this biomarker adds to the diagnosis of Parkinson disease. [WATCH TIME: 3 minutes]

© 2025 MJH Life Sciences

All rights reserved.